Financial statements >
Notes >
Notes on the consolidated statement of financial position >
26. Noncontrolling interest
- 13. Cash and cash equivalents
- 14. Trade accounts receivable
- 15. Inventories
- 16. Other current and non-current assets
- 17. Property, plant and equipment
- 18. Goodwill and other intangible assets
- 19. Other accrued expenses
- 20. Other liabilities
- 21. Debt and capital lease obligations
- 22. Senior Notes
- 23. Mandatory Exchangeable Bonds
- 24. Trust preferred securities
- 25. Pensions and similar obligations
- 26. Noncontrolling interest
- 27. Fresenius SE shareholders’ equity
- 28. Other comprehensive income (loss)
26. Noncontrolling interest
As of December 31, noncontrolling interest in the Group was as follows:
in million € | 2009 | 2008 |
---|---|---|
Noncontrolling interest in Fresenius Medical Care AG & Co. KGaA | 3,050 | 2,751 |
Noncontrolling interest in HELIOS Kliniken GmbH | 4 | 4 |
Noncontrolling interest in VAMED AG | 33 | 30 |
Noncontrolling interest in the business segments | ||
Fresenius Medical Care | 145 | 115 |
Fresenius Kabi | 37 | 32 |
Fresenius Helios | 110 | 99 |
Fresenius Vamed | 3 | 2 |
Corporate / Other | 0 | – |
Total noncontrolling interest | 3,382 | 3,033 |
In 2009, noncontrolling interest increased by € 349 million to € 3,382 million. The change resulted from the noncontrolling interest in profit of € 497 million, less dividend payments of € 166 million and other effects, mainly noncontrolling interest in stock options, currency effects and first-time consolidations, in a total amount of € 18 million.
Back to:
25. Pensions and similar obligations
25. Pensions and similar obligations
Continue reading:
27. Fresenius SE shareholders’ equity
27. Fresenius SE shareholders’ equity